200 related articles for article (PubMed ID: 18665423)
1. Older age and larger tumor size predict malignancy in hürthle cell neoplasms of the thyroid.
Zhang YW; Greenblatt DY; Repplinger D; Bargren A; Adler JT; Sippel RS; Chen H
Ann Surg Oncol; 2008 Oct; 15(10):2842-6. PubMed ID: 18665423
[TBL] [Abstract][Full Text] [Related]
2. Demographic and histological subtypes of Hurthle cell tumours of the thyroid in a South African setting.
Malith V; Bombil I; Harran N; Luvhengo TE
S Afr J Surg; 2018 Sep; 56(3):20-23. PubMed ID: 30264938
[TBL] [Abstract][Full Text] [Related]
3. Surgeon-performed ultrasound predictors of malignancy in patients with Hürthle cell neoplasms of the thyroid.
Parikh PP; Allan BJ; Lew JI
J Surg Res; 2013 Sep; 184(1):247-52. PubMed ID: 23535112
[TBL] [Abstract][Full Text] [Related]
4. Oncocytic cell tumors of the thyroid: factors predicting malignancy and influencing prognosis, treatment decisions, and outcomes.
Pisanu A; Di Chiara B; Reccia I; Uccheddu A
World J Surg; 2010 Apr; 34(4):836-43. PubMed ID: 20041243
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
[TBL] [Abstract][Full Text] [Related]
6. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
7. Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy?
Giorgadze T; Rossi ED; Fadda G; Gupta PK; Livolsi VA; Baloch Z
Diagn Cytopathol; 2004 Nov; 31(5):307-12. PubMed ID: 15468114
[TBL] [Abstract][Full Text] [Related]
8. Unilateral lobectomy for Hurthle cell adenoma.
Wasvary H; Czako P; Poulik J; Lucas R
Am Surg; 1998 Aug; 64(8):729-32; discussion 732-3. PubMed ID: 9697901
[TBL] [Abstract][Full Text] [Related]
9. Thyroid Nodule Size as a Predictor of Malignancy in Follicular and Hurthle Neoplasms.
Boonrod A; Akkus Z; Castro MR; Zeinodini A; Philbrick K; Stan M; Erickson D; Erickson B
Asian Pac J Cancer Prev; 2021 Aug; 22(8):2597-2602. PubMed ID: 34452575
[TBL] [Abstract][Full Text] [Related]
10. Hürthle cell neoplasms of the thyroid: are there factors predictive of malignancy?
Chen H; Nicol TL; Zeiger MA; Dooley WC; Ladenson PW; Cooper DS; Ringel M; Parkerson S; Allo M; Udelsman R
Ann Surg; 1998 Apr; 227(4):542-6. PubMed ID: 9563543
[TBL] [Abstract][Full Text] [Related]
11. Hurthle cell neoplasm of the thyroid gland.
Ahmed M; Bin Yousef H; Greer W; Faraz H; Al Sobhi S; Al Zahrani A; Raef H; Al Ghamdi A; Al Kadhi Y; Al Dayel F
ANZ J Surg; 2008 Mar; 78(3):139-43. PubMed ID: 18269475
[TBL] [Abstract][Full Text] [Related]
12. Tumor size predicts malignant potential in Hürthle cell neoplasms of the thyroid.
Sippel RS; Elaraj DM; Khanafshar E; Zarnegar R; Kebebew E; Duh QY; Clark OH
World J Surg; 2008 May; 32(5):702-7. PubMed ID: 18224463
[TBL] [Abstract][Full Text] [Related]
13. Tumor size and age predict the risk of malignancy in Hürthle cell neoplasm of the thyroid and can therefore guide the extent of initial thyroid surgery.
Kim TH; Lim JA; Ahn HY; Lee EK; Min HS; Won Kim K; Choi YH; Park YJ; Park DJ; Kim KH; Youn YK; Cho BY
Thyroid; 2010 Nov; 20(11):1229-34. PubMed ID: 20929403
[TBL] [Abstract][Full Text] [Related]
14. Surgery for thyroid Hürthle cell tumours--a single institution experience.
Paunovic I; Krgovic K; Tatic S; Diklic A; Zivaljevic V; Kalezic N; Havelka M
Eur J Surg Oncol; 2006 May; 32(4):458-61. PubMed ID: 16497473
[TBL] [Abstract][Full Text] [Related]
15. [Predictive factors for malignancy in Hürthle-cell thyroid neoplasia. Effect of surgical treatment].
Pisanu A; Aste L; Piu S; Cois A; Uccheddu A
Tumori; 2003; 89(4 Suppl):223-5. PubMed ID: 12903600
[TBL] [Abstract][Full Text] [Related]
16. The prevalence and surgical outcomes of Hürthle cell lesions in FNAs of the thyroid: A multi-institutional study in 6 Asian countries.
Agarwal S; Bychkov A; Jung CK; Hirokawa M; Lai CR; Hong S; Kwon HJ; Rangdaeng S; Liu Z; Su P; Kakudo K; Jain D
Cancer Cytopathol; 2019 Mar; 127(3):181-191. PubMed ID: 30668897
[TBL] [Abstract][Full Text] [Related]
17. Hurthle cell tumor.
Chen HY; Benjamin LB; Chen MF
Int Surg; 1996; 81(2):168-70. PubMed ID: 8912085
[TBL] [Abstract][Full Text] [Related]
18. Malignancy risk for solitary and multiple nodules in Hürthle cell-predominant thyroid fine-needle aspirations: A multi-institutional study.
Wong KS; Jo VY; Lowe AC; Faquin WC; Renshaw AA; Shah AA; Roh MH; Stelow EB; Krane JF
Cancer Cytopathol; 2020 Jan; 128(1):68-75. PubMed ID: 31751003
[TBL] [Abstract][Full Text] [Related]
19. Thyroid Hürthle cell tumors: research of potential markers of malignancy.
Donatini G; Beaulieu A; Castagnet M; Kraimps JL; Levillain P; Fromont G
J Endocrinol Invest; 2016 Feb; 39(2):153-8. PubMed ID: 26188382
[TBL] [Abstract][Full Text] [Related]
20. Surgical treatment of Hurthle cell tumors of the thyroid.
Chao TC; Lin JD; Chen MF
World J Surg; 2005 Feb; 29(2):164-8. PubMed ID: 15650796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]